Skip to the answer

Emtricitabine / Tenofovir Disoproxil Uses, Dosage, Side Effects and Interactions

Brand names
Truvada

Truvada was the first emtricitabine / tenofovir disoproxil product the FDA approved, in August 2004. An FDA-approved generic with the same active ingredients is listed.

Emtricitabine/TDF

Emtricitabine/TDF is a brand of emtricitabine / tenofovir disoproxil that comes as a tablet. An FDA-approved generic with the same active ingredients is listed.

Emtricitabine / tenofovir disoproxil is a two-drug HIV medicine used to treat HIV-1 infection (with other HIV medicines) and, in adults at high risk, to help prevent sexually acquired HIV-1.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About Emtricitabine / Tenofovir DisoproxilType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Emtricitabine / Tenofovir Disoproxil in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Emtricitabine / tenofovir disoproxil (Truvada), on the market since about 2004 and with FDA-approved generics listed, pairs two drugs that block an enzyme HIV needs to copy itself; it treats HIV-1 alongside other HIV medicines and, as the original PrEP (pre-exposure prophylaxis) medicine, lowers the risk of getting HIV-1 through sex in adults at high risk. Most people tolerate it well; nausea, diarrhea, headache or tiredness are common early and often ease within weeks. Its boxed warning covers rare, possibly fatal lactic acidosis (acid buildup in the blood) with liver enlargement, severe hepatitis B flares after stopping, and drug-resistant HIV if PrEP is started during an undetected infection.

Key Takeaways From the HelloPharmacist Team

  • Take one tablet once a day, with or without food, and do not skip doses, since PrEP protects best when taken every day.
  • Expect hepatitis B testing first, regular blood and urine kidney checks, and on PrEP an HIV test about every 3 months.
  • Never stop it on your own, especially if you have hepatitis B, because stopping can set off a severe liver flare.
  • Avoid regular or combined use of NSAID pain relievers like ibuprofen and naproxen, which can add strain to your kidneys.

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Emtricitabine / Tenofovir Disoproxil.

This medicine carries a boxed warning, the FDA's strongest warning, with three main risks.

  • Lactic acidosis and severe liver enlargement with fat buildup: These have been reported, including fatal cases, with this type of drug.
  • Hepatitis B flare-ups: It is not approved to treat hepatitis B. People with both HIV-1 and hepatitis B can have severe flares after stopping it. Liver function should be monitored closely for at least several months after stopping, and hepatitis B treatment may be needed.
  • Drug resistance with PrEP: Truvada for PrEP must only be given to people confirmed HIV-negative before starting and at least every 3 months. If someone has an undetected early HIV infection, resistant HIV can develop. Do not start PrEP if there are signs of acute HIV infection unless a negative status is confirmed.
Read the full warning on DailyMed →

Emtricitabine / Tenofovir Disoproxil by the Numbers

Strengths
4
in one form
Makers and packagers
25
Earliest FDA record
2004
Rank by Medicaid prescriptions
#304 of 1,682 drugs
More prescriptions than 81% of the 1,682 drugs we measure
354,223 prescriptions, Q1–Q4 2025

Patient Information Guide for Emtricitabine / Tenofovir Disoproxil

What It’s Used For

This combination is used for HIV-1 treatment and, for the Truvada brand, prevention.

  • Treatment of HIV-1 infection, together with other antiretroviral medicines, in adults and children weighing at least 17 kg (Truvada).
  • Pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults at high risk, along with safer sex practices (Truvada).

How It Works

The tablet contains two antiviral drugs, emtricitabine and tenofovir disoproxil fumarate. Both are nucleoside analog reverse transcriptase inhibitors. They block an enzyme HIV-1 needs to make copies of itself.

Drug Class

Drug Class

  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor from emtricitabine
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Emtricitabine / Tenofovir Disoproxil has two active ingredients, so each class says which one it comes from.

Drug Class

Established Pharmacologic Class (EPC)
  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor from emtricitabine

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Nucleoside Reverse Transcriptase Inhibitors from emtricitabine

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Emtricitabine / Tenofovir Disoproxil in the FDA’s index.

From our Patient Information GuideThe tablet contains two antiviral drugs, emtricitabine and tenofovir disoproxil fumarate. Both are nucleoside analog reverse transcriptase inhibitors. They block an enzyme HIV-1 needs to make copies of itself. Read How Emtricitabine / Tenofovir Disoproxil Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)
  • Nucleosides from emtricitabine

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Antivirals for treatment of HIV infections, combinations

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

The tablet is swallowed once a day, with or without food. The regular tablet is for people weighing at least 35 kg, and a low-strength tablet is used for children weighing at least 17 kg.

People with reduced kidney function may need a different schedule or may not be able to take it. Follow your prescriber and the label.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Emtricitabine / Tenofovir Disoproxil Emtricitabine Tenofovir Disoproxil Tablets

HIV-1 infection treatment
Adults and children weighing at least 35 kg Usual dose 1 tablet (200 mg FTC and 300 mg TDF) once a day
  • One tablet (containing 200 mg of FTC and 300 mg of TDF) once daily taken orally with or without food

TDF stands for tenofovir disoproxil fumarate.

Children weighing 17 to less than 22 kg Usual dose One 100 mg/150 mg tablet once a day

Good to know

Weight should be monitored periodically and dose adjusted

Children weighing 22 to less than 28 kg Usual dose One 133 mg/200 mg tablet once a day

Good to know

Weight should be monitored periodically and dose adjusted

Children weighing 28 to less than 35 kg Usual dose One 167 mg/250 mg tablet once a day

Good to know

Weight should be monitored periodically and dose adjusted

Adults with mild or normal kidney function Every 24 hours

Good to know

Dosing interval adjustment for kidney function

Adults with moderate kidney problems Usual dose 1 tablet every 48 hours

Good to know

Closely monitor response and kidney function

Adults with severe kidney problems or on hemodialysis Not recommended
Lowering the risk of getting HIV-1 (PrEP)
For adults and teens weighing at least 35 kg who do not have HIV-1
Usual dose 1 tablet (200 mg FTC and 300 mg TDF) once a day
  • One tablet (containing 200 mg of FTC and 300 mg of TDF) once daily taken orally with or without food

Good to know

Not recommended if CrCl is below 60 mL/min

TDF stands for tenofovir disoproxil fumarate.

CrCl means creatinine clearance, a measure of how well the kidneys work.

See the Full Dosing Instructions on DailyMed →

Emtricitabine / Tenofovir Disoproxil Truvada Tablets

HIV-1 infection treatment
Adults and children weighing 35 kg or more Usual dose 1 tablet (200 mg of emtricitabine emtricitabine and 300 mg of tenofovir tenofovir disoproxil fumarate) once a day
  • One tablet (containing 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate) once daily taken orally with or without food
Children weighing 17 to less than 22 kg Usual dose One 100/150 tablet once a day

Good to know

Weight should be monitored periodically

Children weighing 22 to less than 28 kg Usual dose One 133/200 tablet once a day

Good to know

Weight should be monitored periodically

Children weighing 28 to less than 35 kg Usual dose One 167/250 tablet once a day

Good to know

Weight should be monitored periodically

Adults with moderate kidney problems Usual dose 1 tablet every 48 hours

Good to know

Closely monitor response and kidney function

Lowering the risk of getting HIV-1 (PrEP)
For adults who do not have HIV-1
Usual dose 1 tablet (200 mg of emtricitabine emtricitabine and 300 mg of tenofovir tenofovir disoproxil fumarate) once a day
  • One tablet (containing 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate) once daily taken orally with or without food

Good to know

Do not use if estimated creatinine clearance is below 60 mL/min

See the Full Dosing Instructions on DailyMed →

Side Effects

In people with HIV-1, common side effects include:

Common side effects

  • Diarrhea
  • Nausea
  • Fatigue
  • Headache
  • Dizziness
  • Depression
  • Trouble sleeping or unusual dreams
  • Rash

When to get medical help

  • Call your doctor right away if you have signs of lactic acidosis or liver problems. The label warns these can be fatal.
  • Tell your doctor if you have hepatitis B and stop or plan to stop this medicine. Hepatitis B can flare up severely.
  • Report new or worsening kidney problems, which can include kidney failure and Fanconi syndrome (a kidney tube disorder).
  • If you take it for PrEP and develop flu-like or other symptoms of new HIV infection, contact your provider promptly.
  • Report signs of immune reconstitution syndrome (the immune system reacting to old infections once HIV is controlled).
  • Tell your doctor if you have a bone fracture or bone pain, since this medicine can lower bone density.

In PrEP trials, headache, abdominal pain and weight decrease were more common than with placebo. Skin darkening on the palms or soles was generally mild. Report signs of kidney, liver or bone problems to your doctor.

Warnings and Precautions

  • Boxed warning: lactic acidosis with severe liver enlargement, hepatitis B flares after stopping, and drug resistance if used for PrEP during undetected early HIV infection.
  • Kidney injury, including kidney failure and Fanconi syndrome. Avoid nephrotoxic drugs.
  • Decreased bone mineral density.
  • Body fat redistribution and immune reconstitution syndrome.
  • Not recommended as part of a triple nucleoside-only regimen, because early treatment failure has been reported.
  • PrEP is not always effective, so use it with other prevention measures and take every dose.

Interactions

Several medicines can change drug levels or add kidney strain.

  • Other emtricitabine, tenofovir or lamivudine products: do not combine.
  • Hepsera (adefovir): do not combine.
  • Didanosine: levels rise, raising risk of pancreatitis and neuropathy.
  • Atazanavir: levels fall, so it should be given with ritonavir.
  • Lopinavir/ritonavir, darunavir/ritonavir and some hepatitis C medicines: tenofovir levels rise.
  • Acyclovir, valacyclovir, ganciclovir, aminoglycosides and high-dose or multiple NSAIDs: may raise drug levels and affect the kidneys.

Interactions Listed in the FDA-Approved Label

From the Emtricitabine / Tenofovir Disoproxil prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Didanosine
    What happensTenofovir disoproxil fumarate increases didanosine concentrations, which could worsen didanosine side effects such as pancreatitis and neuropathy.
    What to doMonitor closely and discontinue didanosine if reactions develop; in patients weighing greater than 60 kg, reduce didanosine dose to 250 mg; no dose recommendation for those under 60 kg.
  • Atazanavir, lopinavir/ritonavir, atazanavir/ritonavir, darunavir/ritonavir (HIV-1 protease inhibitors)
    What happensAtazanavir concentrations decrease and tenofovir concentrations increase.
    What to doGive atazanavir 300 mg with ritonavir 100 mg; monitor for TDF-associated adverse reactions and discontinue the tablets if they develop.
  • Sofosbuvir/velpatasvir, sofosbuvir/velpatasvir/voxilaprevir, ledipasvir/sofosbuvir (hepatitis C agents)
    What happensTenofovir concentrations increase.
    What to doMonitor for TDF-associated adverse reactions; with HARVONI plus an HIV-1 protease inhibitor/ritonavir or cobicistat, consider an alternative HCV or antiretroviral therapy, or monitor if coadministration is necessary.
  • Drugs eliminated by active tubular secretion (acyclovir, adefovir dipivoxil, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides, high-dose or multiple NSAIDs)
    What happensMay increase concentrations of FTC, tenofovir, and/or the coadministered drug.
  • Drugs that decrease renal function
    What happensMay increase concentrations of FTC and/or tenofovir.
Read the label’s full interactions text

7 DRUG INTERACTIONS Tenofovir disoproxil fumarate increases didanosine concentrations. Dose reduction and close monitoring for didanosine toxicity are warranted. Coadministration decreases atazanavir concentrations. When coadministered with emtricitabine and tenofovir disoproxil fumarate tablets, use atazanavir given with ritonavir. Coadministration of emtricitabine and tenofovir disoproxil fumarate tablets with certain HIV-1 protease inhibitors or certain drugs to treat HCV increases tenofovir concentrations. Monitor for evidence of tenofovir toxicity. Consult Full Prescribing Information prior to and during treatment for important drug interactions. 7.1 Drugs Affecting Renal Function FTC and tenofovir are primarily excreted by the kidneys by a combination of glomerular filtration and active tubular secretion. No drug-drug interactions due to competition for renal excretion have been observed; however, coadministration of emtricitabine and tenofovir disoproxil fumarate tablets with drugs that are eliminated by active tubular secretion may increase concentrations of FTC, tenofovir, and/or the coadministered drug. Some examples include, but are not limited to, acyclovir, adefovir dipivoxil, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides (e.g., gentamicin), and high-dose or multiple NSAIDs. Drugs that decrease renal function may increase concentrations of FTC and/or tenofovir. 7.2 Established and Significant Interactions Table 7 provides a listing of established or clinically significant drug interactions.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use for PrEP if HIV-1 status is unknown or positive.
  • Get tested for hepatitis B before starting.
  • Have kidney function and urine tests checked before and during use.
  • Kidney impairment can limit use or change the dosing schedule.
  • Tell your doctor about fracture history or bone loss risk.
  • Pregnancy: observational data show no increased risk of major birth defects, and a pregnancy registry exists.
  • Mothers with HIV-1 should not breastfeed.
  • Pharmacokinetics have not been fully evaluated in people 65 and older.

Overdose

If an overdose occurs, the person should be monitored for signs of toxicity and given standard supportive care. In small studies, higher-than-usual doses of the individual components did not cause severe reactions. Hemodialysis removes some of each drug.

Half-Life and How Your Body Processes It

Both drugs are absorbed after swallowing. Emtricitabine is well absorbed, with peak levels in 1 to 2 hours, and tenofovir peaks in about 1 hour. Food does not affect emtricitabine and modestly raises tenofovir, so the tablet can be taken with or without food. Both are cleared mainly by the kidneys. The half-life is about 10 hours for emtricitabine and about 17 hours for tenofovir.

Storage

Store at 25 °C (77 °F), excursions permitted to 15 °C–30 °C (59 °F–86 °F) (see USP Controlled Room Temperature).

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Emtricitabine / Tenofovir Disoproxil: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Emtricitabine / Tenofovir Disoproxil — the kind of thing our pharmacy team would talk through with you at the counter.

What is this medicine for?

It treats HIV-1 infection when taken with other HIV medicines. The Truvada brand can also be used as PrEP to lower the chance of getting HIV-1 through sex in adults at high risk. For PrEP, it should be paired with safer sex practices.

How do I take it?

Take one tablet by mouth once a day, with or without food. Try to take it at the same time daily. For PrEP, missing doses lowers protection, so consistency really matters. Follow your prescriber's directions.

What side effects should I expect?

Some people get diarrhea, nausea, tiredness, headache or dizziness. Trouble sleeping, vivid dreams, depression and rash can also happen. Call your doctor if you notice signs of kidney, liver or bone problems.

Why do I need so many blood and urine tests?

Your team checks for hepatitis B before you start, and checks kidney function and urine regularly because this medicine can affect the kidneys. If you take it for PrEP, you also need HIV tests at least every 3 months to make sure you're still HIV-negative.

Is it safe to stop if I have hepatitis B?

Don't stop on your own. Hepatitis B can flare up severely after stopping, so your liver needs close monitoring for several months, and you may need hepatitis B treatment.

Can I take it with my other medicines?

Check with me first. Don't combine it with other products containing emtricitabine, tenofovir or lamivudine, or with Hepsera. Some HIV and hepatitis C medicines, didanosine and frequent NSAID use can also need extra monitoring or dose changes.

Is emtricitabine / tenofovir disoproxil available over the counter?

No. Emtricitabine / tenofovir disoproxil is a prescription medicine: every emtricitabine / tenofovir disoproxil product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was emtricitabine / tenofovir disoproxil first available?

The earliest FDA record we hold for emtricitabine / tenofovir disoproxil is from 2004: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when emtricitabine / tenofovir disoproxil was first used.

Who makes emtricitabine / tenofovir disoproxil?

25 companies currently list emtricitabine / tenofovir disoproxil products in the FDA's NDC Directory, including Amneal Pharmaceuticals NY LLC, Aurobindo Pharma Limited, Gilead Sciences, Inc. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of emtricitabine / tenofovir disoproxil?

Emtricitabine / tenofovir disoproxil is the generic name. Its brand names are Truvada and Emtricitabine/TDF. Generic versions are listed under the name emtricitabine / tenofovir disoproxil.

What is the generic name of Truvada?

The generic name of Truvada is emtricitabine / tenofovir disoproxil. A generic name is the name of the active ingredients, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is emtricitabine / tenofovir disoproxil?

Emtricitabine / tenofovir disoproxil belongs to the drug class HIV Nucleoside Analog Reverse Transcriptase Inhibitor, its established pharmacologic class on the FDA label.

Is there a generic version of emtricitabine / tenofovir disoproxil?

Yes. FDA-approved generic versions of emtricitabine / tenofovir disoproxil are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does emtricitabine / tenofovir disoproxil come in?

Emtricitabine / tenofovir disoproxil is listed in the FDA's National Drug Code Directory in these forms and strengths. Tablet (by mouth): 100 mg/150 mg, 133 mg/200 mg, 167 mg/250 mg and 200 mg/300 mg. A listing does not mean every pharmacy stocks every strength.

How much does emtricitabine / tenofovir disoproxil cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $0.51 to $9.36 per generic tablet across 2 strengths and $59.59 per EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg tablet of brand-name Truvada as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Where can I read the emtricitabine / tenofovir disoproxil prescribing information (package insert)?

The full FDA-approved prescribing information for emtricitabine / tenofovir disoproxil, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from NuCare Pharmaceuticals,Inc.'s, revised Jul 16, 2024, and links to it on DailyMed.

Is emtricitabine / tenofovir disoproxil gluten free?

No emtricitabine / tenofovir disoproxil label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 49 emtricitabine / tenofovir disoproxil products from 25 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's emtricitabine / tenofovir disoproxil by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See emtricitabine / tenofovir disoproxil inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Emtricitabine / Tenofovir Disoproxil

Skip the scrolling. Ask in your own words and get an answer from Emtricitabine / Tenofovir Disoproxil’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Emtricitabine / Tenofovir Disoproxil’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Emtricitabine / Tenofovir Disoproxil on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, usually within a day.
Detailed Data & References for Emtricitabine / Tenofovir Disoproxil Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Emtricitabine / Tenofovir Disoproxil Forms and Strengths (How It Comes)

Emtricitabine / Tenofovir Disoproxil comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Emtricitabine / Tenofovir Disoproxil inactive ingredients by manufacturer.

Tablet

By mouth
Brands Truvada (the first brand, 2004) Emtricitabine/TDF
How this form is used
What it may be used for
  • Truvada is used with other antiretroviral medicines to treat HIV-1 infection in adults and children weighing at least 17 kg.
  • Truvada is used with safer sex practices as PrEP to reduce the risk of sexually acquired HIV-1 in adults at high risk.
Important instructions
  • Truvada tablets are taken by mouth once daily, with or without food.
  • Emtricitabine and Tenofovir Disoproxil Fumarate tablets are taken by mouth once daily, with or without food.
  • Truvada low-strength tablets are used for children weighing at least 17 kg, based on body weight.
  • For Truvada PrEP, HIV-1 testing is needed before starting and at least every 3 months.
Available strengths 4 strengths
49 FDA-listed product records ⓘ

Emtricitabine / Tenofovir Disoproxil on the U.S. Market: Products, Makers and Brands

How Emtricitabine / Tenofovir Disoproxil appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

25 companies list 49 Emtricitabine / Tenofovir Disoproxil product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2004. Brand names in the directory today include Truvada and Emtricitabine/TDF; the rest are generics.

1
Dose forms ⓘ
25
Labelers (makers, repackagers, distributors)
2
Brand names ⓘ
49
FDA-listed product records ⓘ
2004
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Unfinished tablet, film coated (11) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Amneal Pharmaceuticals NY LLC10%
Aurobindo Pharma Limited8%
Gilead Sciences, Inc8%
NuCare Pharmaceuticals, Inc.8%
Zydus Lifesciences Limited8%
Zydus Pharmaceuticals USA Inc.8%
Other makers49%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Emtricitabine / Tenofovir Disoproxil Is Used (Medicaid Data)

How many Emtricitabine / Tenofovir Disoproxil prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

354,223
Medicaid prescriptions filled (Q1–Q4 2025)
$491.1M paid by Medicaid, before rebates

How commonly is Emtricitabine / Tenofovir Disoproxil prescribed? Of the 1,682 medications we measure, Emtricitabine / Tenofovir Disoproxil ranks #304 by Medicaid prescriptions — more than 82% of them.

Where Emtricitabine / Tenofovir Disoproxil ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Emtricitabine / Tenofovir Disoproxil product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 200 mg / 300 mg oral tablet is the most-dispensed Emtricitabine / Tenofovir Disoproxil product — about 49% of these Medicaid prescriptions.

emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet Most dispensed

172,322 Medicaid prescriptions (Q1–Q4 2025) 49% of Emtricitabine / Tenofovir Disoproxil prescriptions shown $29.4M paid by Medicaid, before rebates ≈ $171 per prescription, before rebates

11 of 93 listed NDCs had Medicaid claims. RxNorm 476556

emtricitabine 100 MG / tenofovir disoproxil fumarate 150 MG Oral Tablet

130 Medicaid prescriptions (Q1–Q4 2025) <1% of Emtricitabine / Tenofovir Disoproxil prescriptions shown $49,516 paid by Medicaid, before rebates ≈ $381 per prescription, before rebates

1 of 14 listed NDCs had Medicaid claims. RxNorm 1744001

Other Emtricitabine / Tenofovir Disoproxil products: packs and listings not matched to one strength and form

181,771 Medicaid prescriptions (Q1–Q4 2025) 51% of Emtricitabine / Tenofovir Disoproxil prescriptions shown $461.6M paid by Medicaid, before rebates ≈ $2,540 per prescription, before rebates

3 of 9 listed NDCs had Medicaid claims.

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 15 of the 116 listed Emtricitabine / Tenofovir Disoproxil NDCs had Medicaid claims.

Compare Emtricitabine / Tenofovir Disoproxil Products

A representative set of FDA-listed product records for Emtricitabine / Tenofovir Disoproxil — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 49 of 49 products — FDA National Drug Code Directory. See every product, package size and price: browse all 49 Emtricitabine / Tenofovir Disoproxil NDCs →

Emtricitabine / Tenofovir Disoproxil Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Emtricitabine / Tenofovir Disoproxil recalls since July 2021.

✅No Emtricitabine / Tenofovir Disoproxil recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Emtricitabine / Tenofovir Disoproxil in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one exact combination of ingredients (MIN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. A different combination is a different concept with its own page.

Dose forms
1
Strengths
4
Forms in current FDA listings
1 of 1
In current FDA listings No current FDA listing
Multiple ingredients (MIN) Emtricitabine / Tenofovir Disoproxil RxCUI 1008145

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Emtricitabine / Tenofovir Disoproxil Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Emtricitabine / Tenofovir Disoproxil: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick the generic or the brand and a strength to see how its price has changed since Nov 2023.

Version
Strength

At this strength, Truvada costs pharmacies $59.59 per tablet.

For the generic EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg tablet, pharmacies paid an average of $0.512 per tablet as of Nov 18, 2026, down 6% from $0.544 a year earlier. At this strength, Truvada costs pharmacies $59.59 per tablet.

What pharmacies pay now
$0.512
per tablet, as of Nov 18, 2026
Last 4 weeks
Down 2.8%
from $0.526 on Oct 21, 2026
Last 12 months
Down 6%
from $0.544 on Nov 19, 2025
Lowest and highest since Nov 2023
$0.426 to $0.615
per tablet

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg tablet: the average pharmacy price per tablet, the last survey of each month
MonthPharmacy price
Nov 2026$0.512
Oct 2026$0.526
Sep 2026$0.529
Aug 2026$0.505
Jul 2026$0.476
Jun 2026$0.457
May 2026$0.451
Apr 2026$0.453
Mar 2026$0.457
Feb 2026$0.476
Jan 2026$0.488
Dec 2025$0.524
Nov 2025$0.544
Oct 2025$0.579
Sep 2025$0.587
Aug 2025$0.590
Jul 2025$0.578
Jun 2025$0.585
May 2025$0.602
Apr 2025$0.605
Mar 2025$0.603
Feb 2025$0.569
Jan 2025$0.526
Dec 2024$0.523
Nov 2024$0.445
Oct 2024$0.600
Sep 2024$0.559
Aug 2024$0.602
Jul 2024$0.455
Jun 2024$0.585
May 2024$0.426
Apr 2024$0.455
Mar 2024$0.537
Feb 2024$0.593
Jan 2024$0.579
Dec 2023$0.552
Nov 2023$0.615
FormStrengthVersion What pharmacies pay
Tablet · Oral EMTRICITABINE 100 mg/1; TENOFOVIR DISOPROXIL FUMARATE 150 mg Generic $9.36 per tablet NDC details & price history
Tablet · Oral EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg Generic $0.512 per tablet NDC details & price history
Tablet · Oral EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg Truvada (brand) $59.59 per tablet NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Emtricitabine / Tenofovir Disoproxil Brand Names

Emtricitabine / Tenofovir Disoproxil has 2 brand names on record: Truvada and Emtricitabine/TDF. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Truvada the first brand, 2004 Emtricitabine/TDF

Who Makes Emtricitabine / Tenofovir Disoproxil: Manufacturers and Labelers

25 companies list Emtricitabine / Tenofovir Disoproxil products with the FDA. By number of product records, the largest are Amneal Pharmaceuticals NY LLC, Aurobindo Pharma Limited, Gilead Sciences, Inc. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Amneal Pharmaceuticals NY LLC 5 Aurobindo Pharma Limited 4 Gilead Sciences, Inc 4 NuCare Pharmaceuticals, Inc. 4 Zydus Lifesciences Limited 4 Zydus Pharmaceuticals USA Inc. 4 A-S Medication Solutions 3 Cipla USA Inc. 2 DirectRx 2 Proficient Rx LP 2 AvKARE 1 Bryant Ranch Prepack 1 Camber Pharmaceuticals, Inc. 1 Exelan Pharmaceuticals, Inc. 1 Golden State Medical Supply, Inc. 1 Laurus Labs Limited 1 Lupin Pharmaceuticals, Inc. 1 Macleods Pharmaceuticals Limited 1 Major Pharmaceuticals 1 NorthStar RxLLC 1 Quallent Pharmaceuticals Health Llc 1 Redpharm Drug 1 Strides Pharma Inc. 1 Strides Pharma Science Limited 1

…and 1 more on the FDA NDC directory.

Sources for This Emtricitabine / Tenofovir Disoproxil Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Jul 16, 2024, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Emtricitabine / Tenofovir Disoproxil.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 44 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
44
Finished products in the current FDA directory
49
Companies listing them (makers, repackagers, distributors)
25
FDA labeler codes behind them ⓘ
28
Linked representative label ⓘ
NuCare Pharmaceuticals,Inc.
Linked label effective
Jul 16, 2024
Composite sections available
24
Linked SPL Set ID
46e06df0-654d-43cc-e054-00144ff8d46c
Linked SPL Document ID
1d609fda-9b9e-40b3-e063-6294a90a63b9
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. NuCare Pharmaceuticals,Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →